Pavlovic Quoted in Inside Health Policy on Urge for FDA to Release Post-Pandemic Flexibility Plans

Device Makers Want FDA To Preview Post-Pandemic Flexibility Plans
– Inside Health Policy

Manatt Health partner Yarmela Pavlovic spoke with Inside Health Policy on the uncertainty medical device manufacturers are facing in light of the COVID-19 pandemic, particularly as they create longer-term post-pandemic business plans without knowing what FDA guidance will look like. In the article, Pavlovic noted that uncertainty is the largest concern for companies, saying, “I completely understand the need to be fast and engage in policy development that is very rapid. I also think from a regulatory policy standpoint, there is probably more FDA could do to outline their expectations for companies as this goes forward and I think that will give companies a little more certainty.”



pursuant to New York DR 2-101(f)

© 2020 Manatt, Phelps & Phillips, LLP.

All rights reserved